Researchers gather for stem cell retreat

November 8, 2013 by Carolyn Pennington

Scientists from across the state are gathering for a retreat at the Health Center today to present their latest findings in the field of stem cell research. Among those making presentations include researchers from UConn, Yale, Wesleyan, The Jackson Laboratory, and Pfizer pharmaceuticals.

Significant findings have been made since 2005, when the General Assembly first passed legislation committing $100 million for stem cell research over 10 years. The initiative has helped support major scientific advances, state-of-the-art research facilities, and the creation of new jobs.

Marc Lalande, director of the UConn Stem Cell Institute, told the gathering that with the state's investment, UConn has been able to grow a successful stem cell community with over 40 labs and more than 70 investigators.

"We've been able to develop technology and increase economic development that is being spurred by ," explained Lalande, "and that is extremely important given the investment the state is making in Bioscience Connecticut."

Lalande went on to say that "induced pluripotent stem (iPS) cells revolutionized by allowing us to make patient specific . The UConn Stem Cell Core lab manager, Leann Crandall, has made over a 100 of these stem cells lines and has sent them all over the world. So we're extremely proud of the technology we've developed which I think is cutting edge."

This video is not supported by your browser at this time.

Among the presenters at the retreat was Dr. Ren-He Xu, director of the UConn Stem Cell Core. He discussed "Correction of a Genetic Disease in Human Stem Cells," specifically involving his research into Marfan syndrome. Using "genetic editing" techniques, Xu is getting closer to identifying potential drug therapies that could help Marfan patients.

Explore further: Predicting the fate of stem cells

Related Stories

Predicting the fate of stem cells

October 22, 2013

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. ...

Scientists isolate new human pluripotent stem cells

October 31, 2013

One of the obstacles to employing human embryonic stem cells for medical use lies in their very promise: They are born to rapidly differentiate into other cell types. Until now, scientists have not been able to efficiently ...

Why stem cells need to stick with their friends

November 7, 2013

Scientists at University of Copenhagen and University of Edinburgh have identified a core set of functionally relevant factors which regulates embryonic stem cells' ability for self-renewal. A key aspect is the protein Oct4 ...

Recommended for you

New gene map reveals cancer's Achilles heel

November 25, 2015

Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.

Insect DNA extracted, sequenced from black widow spider web

November 25, 2015

Scientists extracted DNA from spider webs to identify the web's spider architect and the prey that crossed it, according to this proof-of-concept study published November 25, 2015 in the open-access journal PLOS ONE by Charles ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.